Veracyte | VCYT - أصول متداولة





أصول متداولة تغيير تاريخ
Agenus USD 78.81M 16.47M 2026-06
Agilent USD 4.69B 70M 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.29B 382.19M 2026-09
Bruker USD 2.16B 67.9M 2026-09
Heron Therapeutics USD 209.11M 20.73M 2026-09
Illumina USD 3.04B 201M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Laboratory Of America USD 3.97B 151.3M 2026-09
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
Myriad Genetics USD 289M 23.8M 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Siemens EUR 68.86B 3.72B 2026-09
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
Veracyte USD 467.88M 106.9M 2026-09
Waters USD 3.9B 186M 2026-06